No Data
No Data
Jim Cramer on ARS Pharmaceuticals: "It's a Great Flier"
Jim Cramer Is All Aboard Union Pacific, But Shows No Love For Orphan Drugs
Earnings Call Summary | ARS Pharmaceuticals(SPRY.US) Q1 2025 Earnings Conference
William Blair Remains a Buy on ARS Pharmaceuticals (SPRY)
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
ARS Pharmaceuticals Shares Are Trading Higher on Possible Continued Strength After Reporting a Q1 Revenue Beat Earlier Mid-week.
Gen Xeno : Which of these were day trades?
Swami : Nice!!!
Christopher Cioc : good lord
I wish I had money to play like that! I'm happy I finally ended my losing streak before I lost all my play money!